DK1200088T3 - Sammensætning indeholdende paracetamol og drotaverin - Google Patents

Sammensætning indeholdende paracetamol og drotaverin

Info

Publication number
DK1200088T3
DK1200088T3 DK00949829T DK00949829T DK1200088T3 DK 1200088 T3 DK1200088 T3 DK 1200088T3 DK 00949829 T DK00949829 T DK 00949829T DK 00949829 T DK00949829 T DK 00949829T DK 1200088 T3 DK1200088 T3 DK 1200088T3
Authority
DK
Denmark
Prior art keywords
drotaverine
composition containing
active ingredient
containing paracetamol
additional active
Prior art date
Application number
DK00949829T
Other languages
English (en)
Inventor
Boglarka Jakab
Morvai Magdolna Vitanyine
Peterne Kovacs
Mathe Irma Kalmanne
Erzsebet Vegeli
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Application granted granted Critical
Publication of DK1200088T3 publication Critical patent/DK1200088T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK00949829T 1999-07-28 2000-07-28 Sammensætning indeholdende paracetamol og drotaverin DK1200088T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9902559A HU225779B1 (en) 1999-07-28 1999-07-28 Pharmaceutical composition containing paracetamol and drotaverine and process for producing it
PCT/HU2000/000086 WO2001007024A2 (en) 1999-07-28 2000-07-28 Paracetamol and drotaverine containing composition

Publications (1)

Publication Number Publication Date
DK1200088T3 true DK1200088T3 (da) 2003-09-22

Family

ID=90014235

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00949829T DK1200088T3 (da) 1999-07-28 2000-07-28 Sammensætning indeholdende paracetamol og drotaverin

Country Status (19)

Country Link
EP (1) EP1200088B1 (da)
AT (1) ATE241983T1 (da)
AU (1) AU6308800A (da)
BG (1) BG65553B1 (da)
DE (1) DE60003188T2 (da)
DK (1) DK1200088T3 (da)
EA (1) EA003779B1 (da)
EE (1) EE04952B1 (da)
ES (1) ES2197107T3 (da)
GE (1) GEP20053581B (da)
HR (1) HRP20020071B1 (da)
HU (1) HU225779B1 (da)
ME (2) ME00088B (da)
PL (1) PL197749B1 (da)
PT (1) PT1200088E (da)
RS (1) RS50074B (da)
SI (1) SI1200088T1 (da)
UA (1) UA72535C2 (da)
WO (1) WO2001007024A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2232018C2 (ru) * 2002-10-09 2004-07-10 Открытое акционерное общество "Ирбитский химико-фармацевтический завод" Спазмолитическое лекарственное средство
RU2252024C2 (ru) * 2003-04-22 2005-05-20 Гаврилов Андрей Станиславович Способ получения спазмолитического лекарственного средства
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
RU2704613C2 (ru) * 2014-11-11 2019-10-30 Д-Р Редди'С Лабораторис Лимитед Фармацевтические препараты с фиксированной комбинацией доз обезболивающего и антиспазматического агентов
EP3520781A1 (en) * 2018-02-05 2019-08-07 Adamed sp. z o.o. A pharmaceutical composition comprising metamizole, drotaverine, and caffeine
CN115279346A (zh) * 2020-03-09 2022-11-01 苏什玛·保罗·伯利亚 包含屈他维林或其盐的控制释放制剂
CN115397411B (zh) * 2020-04-23 2025-08-22 浙江养生堂天然药物研究所有限公司 药物组合及其用途
BG113694A (bg) 2023-04-26 2024-10-31 "Адифарм" Еад Фармацевтичен състав под формата на таблетка, съдържаща метамизол, кофеин и дротаверин и метод за нейното получаване
PL451289A1 (pl) * 2025-02-25 2026-04-13 Pikralida Spółka Z Ograniczoną Odpowiedzialnością Kompozycja farmaceutyczna zawierająca naproksen i drotawerynę lub ich farmaceutycznie dopuszczalne sole, sposób jej wytwarzania oraz jej zastosowanie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation

Also Published As

Publication number Publication date
DE60003188T2 (de) 2004-07-01
PT1200088E (pt) 2003-10-31
HUP9902559A2 (hu) 2002-04-29
PL353209A1 (en) 2003-11-03
ME00088B (me) 2010-10-10
MEP18508A (en) 2010-06-10
HU225779B1 (en) 2007-08-28
WO2001007024A3 (en) 2001-03-29
EA200200211A1 (ru) 2002-08-29
HRP20020071A2 (en) 2003-12-31
UA72535C2 (en) 2005-03-15
SI1200088T1 (en) 2003-12-31
BG106368A (en) 2002-08-30
EE200200042A (et) 2003-04-15
EE04952B1 (et) 2008-02-15
EP1200088B1 (en) 2003-06-04
YU6102A (sh) 2005-03-15
DE60003188D1 (de) 2003-07-10
GEP20053581B (en) 2005-07-25
EP1200088A2 (en) 2002-05-02
HUP9902559D0 (en) 1999-10-28
HRP20020071B1 (hr) 2011-01-31
BG65553B1 (bg) 2008-12-30
HUP9902559A3 (en) 2003-05-28
ES2197107T3 (es) 2004-01-01
WO2001007024A2 (en) 2001-02-01
EA003779B1 (ru) 2003-08-28
PL197749B1 (pl) 2008-04-30
AU6308800A (en) 2001-02-13
RS50074B (sr) 2009-01-22
ATE241983T1 (de) 2003-06-15

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
DK1526839T3 (da) Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed
EA200301275A1 (ru) Капсулы для ингаляции
DK1157037T3 (da) GCSF-konjugater
BRPI0414000B8 (pt) composição farmacêutica sólida oral de liberação prolongada contendo tacrolimus na forma de uma dispersão sólida, forma de dosagem, e, uso da composição farmacêutica
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
EE201000019A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
DK1086706T3 (da) Stabiliserede sammensætninger indeholdende nootropiske lægemidler
EA200401019A1 (ru) Дозированная лекарственная форма для перорального применения, содержащая ингибитор pde 4 в качестве действующего вещества и поливинилпирролидон в качестве вспомогательного вещества
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
DE60105448D1 (de) Feste dispersionen mit nitrataktiven wirkstoffen
PT1200088E (pt) Composicao contendo paracetamol e drotaverina
MX9505192A (es) Utilizacion de un antagonista de la substancia p para la obtencion de composiciones farmaceuticas para el tratamiento del enrojecimiento cutaneo de origen neurogenico.
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
NO20012673D0 (no) Nytt farmasöytisk preparat og fremgangsmåte for dets fremstilling
SE0000303D0 (sv) Novel compounds
ATE270551T1 (de) Kombinationspräparat aus 2-methylthiazolidin-2,4- dicarbonsäure und paracetamol
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
BR0313076A (pt) Sal de ácido orgânico de amlodipina
DE60210308D1 (de) Zusammensetzung enthaltend paroxetin und ein pharmazeutisch verträgliches salz von glycyrrhizinsäure
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
AU2003228305A1 (en) Pharmaceutical composition with combined active agents and methods for using the same
MXPA04006675A (es) Composicion farmaceutica que comprende glitazona y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
SI1677808T1 (sl) Kombiniran pripravek za zdravljenje sepse